tirzepatide is fda approved approves weight-loss drug Zepbound to treat sleep apnea – San Diego Union-Tribune Approved by FDA: In May

Both medications depress the central nervous system, which can increase the risk of side effects such as drowsiness, dizziness, and difficulty concentrating

The SURMOUNT-OSA trials demonstrated tirzepatide reduced the apnea-hypopnea index (AHI) by 63-73% in adults with obesity and moderate-to-severe obstructive sleep apnea, approaching the efficacy of CPAP therapy

SilveiraSQda SilvaLMde Campos Vieira AbibAde MouraDTHde MouraEGHSantosLBet al

Tirzepatide (Mounjaro, Zepbound) is a related but distinct dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist

Eli Lillys chief of research, Dr

Feeling drained, inflamed, or run down